Table 2.
Symptom frequency initially, at call, and at 2 follow-up visits
| Symptoms | Initial (N = 106) no. (%)b | Call (N = 106) no. (%)b | Follow-up 1 (n = 101) no. (%)b | Follow-up 2 (n = 95) no. (%)b | Any time pointa; no. (%)b |
|---|---|---|---|---|---|
| Time since initial positive test result, median (IQR), d | NA | 1 (0–30) | 4 (1–33) | 7 (2–36) | NA |
| Time since symptom onset, median (IQR), d | NA | 10 (0–41) | 13 (2–46) | 17 (5–48) | NA |
| Any symptoms | 101 (95.3) | 94 (88.7) | 81 (80.2) | 63 (66.3) | 104 (98.1) |
| Cough | 61 (57.5) | 59 (55.7) | 51 (50.5) | 36 (37.9) | 82 (80.4) |
| Fatigue | 35 (33.0) | 34 (32.1) | 35 (34.7) | 27 (28.4) | 69 (67.6) |
| Fever | 60 (56.6) | 35 (33.0) | 17 (16.8) | 8 (8.4) | 68 (66.0) |
| Headache | 24 (22.6) | 20 (18.9) | 16 (15.8) | 15 (15.8) | 49 (49.0) |
| Any sinus symptoms | 21 (19.8) | 20 (18.9) | 23 (22.8) | 19 (20) | 48 (48.5) |
| Ageusia | 19 (17.9) | 19 (17.9) | 23 (22.8) | 14 (14.7) | 46 (46.9) |
| Gastrointestinal symptoms | 20 (18.9) | 15 (14.2) | 22 (21.8) | 10 (10.5) | 46 (44.2) |
| Myalgia | 31 (29.3) | 14 (13.2) | 8 (7.9) | 4 (4.2) | 38 (39.2) |
| Anosmia | 19 (17.9) | 12 (11.3) | 18 (17.8) | 9 (9.5) | 33 (34.0) |
| Shortness of breath | 12 (11.3) | 14 (13.2) | 15 (14.8) | 10 (10.5) | 29 (29.9) |
| Chest congestion | 11 (10.4) | 8 (7.5) | 11 (10.9) | 11 (11.6) | 26 (27.4) |
| Chills | 15 (14.2) | 8 (7.5) | 5 (4.9) | 3 (3.2) | 24 (24.7) |
| Sore throat | 14 (13.2) | 6 (5.7) | 10 (9.9) | 6 (6.3) | 24 (24.5) |
| Sweats | 8 (7.5) | 7 (6.6) | 5 (5.0) | 4 (4.2) | 16 (16.5) |
| Wheezing | 1 (0.9) | 0 | 2 (2.0) | 3 (3.2) | 5 (5.3) |
| Light-headedness | 2 (1.9) | 1 (0.9) | 3 (3.0) | 0 | 5 (5.2) |
| Malaise | 3 (2.8) | 0 | 1 (1.0) | 0 | 4 (4.2) |
| Dizziness | 1 (0.9) | 1 (0.9) | 0 | 0 | 2 (2.1) |
| Rash | 1 (0.9) | 0 | 2 (2.0) | 1 (1.1) | 2 (2.1) |
| Insomnia | 0 | 2 (1.9) | 0 | 0 | 2 (2.1) |
| Disequilibrium | 1 (0.9) | 0 | 0 | 0 | 1 (1.1) |
| Muscle cramps | 0 | 0 | 0 | 0 | 0 |
| Asymptomatic | 5 (4.7) | 12 (11.3) | 20 (19.8) | 32 (33.7) | 2 (1.9) |
IQR interquartile range, NA not applicable
aConsidered positive if patient reported symptoms at any time during the study. Therefore, denominators vary
bNo. (%) unless otherwise specified